
Clinical
Latest News
Advertisement
Latest Videos

CME Content
Advertisement
More News

Korean drug maker Celltrion Healthcare recently presented new findings from a 2-part study at the Annual European Congress of Rheumatology 2019 meeting about subcutaneous biosimilar CT-P13 (Inflectra, Remsima).
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
2
Patients With CKD Are Less Likely to Receive Adjuvant Chemotherapy
3
Obstructive Sleep Apnea Identified as Potential Risk Factor for Parkinson Disease
4
ICYMI: Highlights From ESMO 2025
5













































